Arcus Biosciences, Inc. (NYSE:RCUS) popped in on a high volume red day. Volume on 11-Jun-19 came in at 216239 contracts. The daily trading volume has averaged 183320 shares a day in past 5 days. The first sale was made at $8.06 but later the stock became weaker, and closed with a fall of -2.75%. It was last traded at $7.79 apiece.Arcus Biosciences, Inc. (RCUS): Buy Candidate With 159.31% Upside Potential
Arcus Biosciences, Inc. is maintained at an average buy rating by 5 stock analysts, and there are at least 4.16% of shares outstanding that are currently legally short sold. The shares went down by -28.2% in value last month. Year-to-date it plunged -27.67%. Analysts are turning out to be more optimistic than before, with 4 of analysts who cover Arcus Biosciences, Inc. (NYSE:RCUS) advice adding it to buy candidate list. Wall Street experts also assign a $20.2 price target on Arcus Biosciences, Inc., pointing towards a 159.31% rally from current levels. The stock is trading for about -55.49% less than its 52-week high.
Arcus Biosciences, Inc. (RCUS) remained unsuccessful in beating the consensus-estimated -$0.35 as it actually earned -$0.41 per share in its last reported financial results. Revenue, on the other hand, scored 3.85% growth from the previous quarter, coming up with $1.62 million.RCUS Retreats -2.87% In A Week
This company shares (RCUS) so far managed to recover 5.27% since collapsing to its 52-week low. Over a week, it has seen its stock price volatility to stay at 5.17% while widening the period to a month, volatility was 6.09%. The share price has yet to cross its 20 days moving average, floating at a distance of -12.79% and sits -25.42% lower versus its 50 days moving average. When looking at the past five sessions, the stock returned -2.87% losses and is down by -31.61% compared with its 200-day moving average of $10.79. Also, Arcus Biosciences, Inc. (RCUS) needs to overturn a -54.04% decrease it experienced over the past twelve months.
As regular trading ended, Axcelis Technologies, Inc. (ACLS) stock brought in a -$0.65 drop to $15.09. The day started at a price of $15.59 but then traded as high as $15.88 before giving part of the gains back. As for this week, analysts appear content to stick with their neutral outlook with the consensus call at 2.2. Axcelis Technologies, Inc. is given 2 buy-equivalent recommendations, 0 sells and 2 holds. The company shares sank -40.05% from their peak of $25.17 and now has a $492.39 million market value of equity.Axcelis Technologies, Inc. Could Grow 64.35% More
ACLS’s mean recommendation on Reuter’s scale presents no change from 2 thirty days ago to 2 now, which indicates a hold consensus from the analyst community. They see Axcelis Technologies, Inc. (ACLS) price hitting a mean target of $24.8 a share, meaning the stock still has potential that could lift the price another 64.35% . Also, the recent close suggests the stock is underpriced by 105.43% compared to the most bullish target.
The company had seen its current volume reaching at 213227 shares in the last trade. That compares with the recent volume average of 211360. At the close of regular trading, its last week’s stock price volatility was 3.58% which for the month reaches 4.39%. Axcelis Technologies, Inc. dipped to as low as $15.04 throughout the day and has returned -15.22% in this year. At one point in the past year, the shares traded as low as $14.47 but has recovered 4.28% since then. [T4]